Skip to content

13F-HR filed by Broadfin Capital, LLC

Broadfin Capital, LLC filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-11-14, with 50 holding rows worth $679,523,000.

Accession
0001511901-18-000006
Filed
2018-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, 50 entries on the cover page, a total value of $679,523,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $679,523,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerBroadfin Healthcare Master Fund Ltd 028-14254

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares Russell 2000 ETF464287655SHS400,000$67,420,000thousands by filing dateput
IOVANCE BIOTHERAPEUTICS INC462260100COM4,894,361$55,062,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 22,053,991$41,347,000thousands by filing date
ZOGENIX INC.98978L204Common Stock657,898$32,632,000thousands by filing date
ADMA BIOLOGICS INC000899104COM4,463,829$27,720,000thousands by filing date
RETROPHIN INC761299106COM938,214$26,955,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM1,328,424$26,595,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW573,079$24,551,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM4,083,135$23,846,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW1,455,000$23,673,000thousands by filing datecall
CORIUM INTL INC21887L107COM2,368,557$22,525,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM5,136,264$19,415,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM357,672$16,846,000thousands by filing date
ANTARES PHARMA INC036642106COM4,623,247$15,534,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH160,000$15,339,000thousands by filing dateput
NANOSTRING TECHNOLOGIES INC63009R109COM850,000$15,156,000thousands by filing date
SOCIETAL CDMO INC75629F109COM2,048,025$14,561,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock2,493,021$13,487,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW196,572$12,948,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD2,563,096$12,431,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO2,792,773$12,260,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM4,375,066$12,250,000thousands by filing date
TELIGENT INC NEW87960W104COM3,052,852$12,059,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock895,553$11,821,000thousands by filing date
HERON THERAPEUTICS INC427746102COM291,213$9,217,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS410,532$8,038,000thousands by filing date
STRATA SKIN SCIENCES INC86272A206COMMON2,181,363$7,722,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM4,090,344$6,954,000thousands by filing date
INTERSECT ENT INC46071F103COM234,200$6,733,000thousands by filing date
SOL GEL TECHNOLOGIESM8694L103SHS847,700$6,358,000thousands by filing date
LIVANOVA PLCG5509L101SHS51,000$6,322,000thousands by filing date
ANGIODYNAMICS INC03475V101COM289,035$6,284,000thousands by filing date
QUOTIENT LTDG73268107SHS804,700$6,075,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW1,948,554$5,768,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM150,000$5,700,000thousands by filing datecall
IDERA PHARMACEUTICALS INC45168K405COM PAR629,340$5,607,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock62,200$5,444,000thousands by filing date
TESARO INC881569107COM125,000$4,876,000thousands by filing datecall
TESARO INC881569107COM104,700$4,084,000thousands by filing date
DEXCOM INC COM252131107Stock24,200$3,462,000thousands by filing date
KALA BIO INC COM483119103Stock346,083$3,416,000thousands by filing date
PERNIX THERAPEUTICS HLDGS IN71426VAK4DBCV 4.250 4/015,000,000$3,375,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM150,000$3,317,000thousands by filing date
HERON THERAPEUTICS INC427746102COM100,000$3,165,000thousands by filing datecall
Viewra, Inc92672L107COM250,000$2,340,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock1,885,904$2,263,000thousands by filing date
ALPHATEC HLDGS INC02081G201COM NEW669,812$2,257,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2100,000$2,013,000thousands by filing datecall
VERICEL CORP92346J108COM132,600$1,876,000thousands by filing date
ONCOMED PHARMACEUTICALS INC COM68234X102Stock200,000$424,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001511901-18-000006this filing2018-11-14acceptance time not in the bulk data set